References:
1. Nathan DM, Turgeon H, Regan S. Relationship between glycated
haemoglobin levels and mean glucose levels over time.Diabetologia . 2007;50(11):2239-2244.
doi:10.1007/s00125-007-0803-0
2. Nathan DM, Balkau B, Bonora E, et al. International expert committee
report on the role of the A1C assay in the diagnosis of diabetes.Diabetes Care . 2009;32(7):1327-1334. doi:10.2337/dc09-9033
3. Zheng J, Cheng J, Wang T, Zhang Q, Xiao X. Does HbA1c Level Have
Clinical Implications in Diabetic Patients Undergoing Coronary Artery
Bypass Grafting? A Systematic Review and Meta-Analysis. Int J
Endocrinol . 2017;2017:1537213. doi:10.1155/2017/1537213
4. Yong PH, Weinberg L, Torkamani N, et al. The presence of diabetes and
higher HbA1c are independently associated with adverse outcomes after
surgery. Diabetes Care . 2018;41(6):1172-1179.
doi:10.2337/dc17-2304
5. Association AD. Diagnosis and classification of diabetes mellitus.Diabetes Care . 2014;37(SUPPL.1):S81-S90. doi:10.2337/dc14-S081
6. Valentine NA, Alhawassi TM, Roberts GW, Vora PP, Stranks SN, Doogue
MP. Detecting undiagnosed diabetes using glycated haemoglobin: An
automated screening test in hospitalised patients. Med J Aust .
2011;194(4):160-164. doi:10.5694/mja11.10534c
7. Bunn HF, Haney DN, Kamin S, Gabbay KH, Gallop PM. The biosynthesis of
human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo. J
Clin Invest . 1976;57(6):1652-1659. doi:10.1172/JCI108436
8. Welsh KJ, Kirkman MS, Sacks DB. Role of Glycated Proteins in the
Diagnosis and Management of Diabetes: Research Gaps and Future
Directions. Diabetes Care . 2016;39:1299-1306.
doi:10.2337/dc15-2727
9. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK.
Significance of HbA1c test in diagnosis and prognosis of diabetic
patients. Biomark Insights . 2016;11:95-104.
doi:10.4137/Bmi.s38440
10. Higgins PJ, Bunn HF. Kinetic analysis of the nonenzymatic
glycosylation of hemoglobin. J Biol Chem . 1981;256(10):5204-5208.
http://www.ncbi.nlm.nih.gov/pubmed/7228877. Accessed March 30, 2020.
11. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end
products: Sparking the development of diabetic vascular injury.Circulation . 2006;114(6):597-605.
doi:10.1161/CIRCULATIONAHA.106.621854
12. Jarolim P, Lahav M, Liu SC, Palek J. Effect of hemoglobin oxidation
products on the stability of red cell membrane skeletons and the
associations of skeletal proteins: correlation with a release of hemin.Blood . 1990;76(10):2125-2131.
http://www.ncbi.nlm.nih.gov/pubmed/2242431. Accessed March 30, 2020.
13. Li YSJ, Haga JH, Chien S. Molecular basis of the effects of shear
stress on vascular endothelial cells. J Biomech .
2005;38(10):1949-1971. doi:10.1016/j.jbiomech.2004.09.030
14. World Health Organization. Use of Glycated Haemoglobin (HbA1c)
in the Diagnosis of Diabetes Mellitus Abbreviated Report of a WHO
Consultation .; 2011.
15. Association AD. 6. Glycemic Targets: Standards of Medical Care in
Diabetes-2020. Diabetes Care . 2020;43(Supplement 1):S66-S76.
doi:10.2337/dc20-S006
16. Ditzel J, Kjærgaard JJ. Haemoglobin AIc concentrations after initial
insulin treatment for newly discovered diabetes. Br Med J .
1978;1(6115):741-742. doi:10.1136/bmj.1.6115.741
17. McGinn JT, Shariff MA, Bhat TM, et al. Prevalence of Dysglycemia
Among Coronary Artery Bypass Surgery Patients with No Previous Diabetic
History. J Cardiothorac Surg . 2011;6(1):104.
doi:10.1186/1749-8090-6-104
18. Kuhl J, Sartipy U, Eliasson B, Nyström T, Holzmann MJ. Relationship
between preoperative hemoglobin A1c levels and long-term mortality after
coronary artery bypass grafting in patients with type 2 diabetes
mellitus. Int J Cardiol . 2016;202:291-296.
doi:10.1016/j.ijcard.2015.09.008
19. Halkos ME, Lattouf OM, Puskas JD, et al. Elevated Preoperative
Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After
Coronary Artery Bypass Surgery. Ann Thorac Surg .
2008;86(5):1431-1437. doi:10.1016/j.athoracsur.2008.06.078
20. Halkos ME, Puskas JD, Lattouf OM, et al. Elevated preoperative
hemoglobin A1c level is predictive of adverse events after coronary
artery bypass surgery. J Thorac Cardiovasc Surg .
2008;136(3):631-640. doi:10.1016/j.jtcvs.2008.02.091
21. Alserius T, Anderson RE, Hammar N, Nordqvist T, Ivert T. Elevated
glycosylated haemoglobin (HbA1c) is a risk marker in coronary artery
bypass surgery. Scand Cardiovasc J . 2008;42(6):392-398.
doi:10.1080/14017430801942393
22. Hudson CCC, Welsby IJ, Phillips-Bute B, et al. Glycosylated
hemoglobin levels and outcome in non-diabetic cardiac surgery patients.Can J Anesth . 2010;57(6):565-572. doi:10.1007/s12630-010-9294-4
23. Arslan Ü, Memetoğlu ME, Kutlu R, et al. Preoperative Hba1c level in
prediction of short-term morbidity and mortality outcomes following
coronary artery bypass grafting surgery. Russ Open Med J .
2015;4(2). doi:10.15275/rusomj.2015.0204
24. Nyström T, Holzmann MJ, Eliasson B, Kuhl J, Sartipy U. Glycemic
control in type 1 diabetes and long-term risk of cardiovascular events
or death after coronary artery bypass grafting. J Am Coll
Cardiol . 2015;66(5):535-543. doi:10.1016/j.jacc.2015.05.054
25. Kim HJ, Shim JK, Youn YN, Song JW, Lee H, Kwak YL. Influence of
preoperative hemoglobin A1c on early outcomes in patients with diabetes
mellitus undergoing off-pump coronary artery bypass surgery. J
Thorac Cardiovasc Surg . 2020;159(2):568-576.
doi:10.1016/j.jtcvs.2019.01.086
26. Narayan P, Kshirsagar SN, Mandal CK, et al. Preoperative
Glycosylated Hemoglobin: A Risk Factor for Patients Undergoing Coronary
Artery Bypass. Ann Thorac Surg . 2017;104(2):606-612.
doi:10.1016/j.athoracsur.2016.12.020
27. Boom W Vanden, Schroeder RA, Manning MW, Setji TL, Fiestan GO,
Dunson DB. Effect of A1c and glucose on postoperative mortality in
noncardiac and cardiac surgeries. Diabetes Care .
2018;41(4):782-788. doi:10.2337/dc17-2232
28. Tsuruta R, Miyauchi K, Yamamoto T, et al. Effect of preoperative
hemoglobin A1c levels on long-term outcomes for diabetic patients after
off-pump coronary artery bypass grafting. J Cardiol .
2011;57(2):181-186. doi:10.1016/j.jjcc.2010.11.003
29. Faritous Z, Ardeshiri M, Yazdanian F, Jalali A, Totonchi Z,
Azarfarin R. Hyperglycemia or high hemoglobin A1C: Which one is more
associated with morbidity and mortality after coronary artery bypass
graft surgery? Ann Thorac Cardiovasc Surg . 2014;20(3):223-228.
doi:10.5761/atcs.oa.13.02282
30. Matsuura K, Imamaki M, Ishida A, Shimura H, Niitsuma Y, Miyazaki M.Off-Pump Coronary Artery Bypass Grafting for Poorly Controlled
Diabetic Patients . Vol 15.; 2009.
31. Santos JM, Favaloro RR, Lowenstein D, Sanabria H, Raffaelli H,
Hershson A. Medium-term glycemic control in diabetics before coronary
bypass surgery. Medicina (B Aires) . 2015;75(5):277-281.
http://www.ncbi.nlm.nih.gov/pubmed/26502461. Accessed April 3, 2020.
32. Ramadan M, Abdelgawad A, Elshemy A, et al. Impact of elevated
glycosylated hemoglobin on hospital outcome and 1 year survival of
primary isolated coronary artery bypass grafting patients. Egypt
Hear J . 2018;70(2):113-118. doi:10.1016/j.ehj.2017.09.002
33. Strahan S, Harvey RM, Campbell-Lloyd A, Beller E, Mundy J, Shah P.
Diabetic control and coronary artery bypass: Effect on short-term
outcomes. Asian Cardiovasc Thorac Ann . 2013;21(3):281-287.
doi:10.1177/0218492312451983
34. Nicolini F, Santarpino G, Gatti G, et al. Utility of glycated
hemoglobin screening in patients undergoing elective coronary artery
surgery: Prospective, cohort study from the E-CABG registry. Int J
Surg . 2018;53:354-359. doi:10.1016/j.ijsu.2018.04.021
35. Subramaniam B, Lerner A, Novack V, et al. Increased glycemic
variability in patients with elevated preoperative hba1c predicts
adverse outcomes following coronary artery bypass grafting surgery.Anesth Analg . 2014;118(2):277-287.
doi:10.1213/ANE.0000000000000100
36. Tee AH, Hasan R, Mclaughlin K, Keenan D, Datta S. Is pre-operative
haemoglobin A1c level a successful predictor of adverse outcome after
cardiac surgery? J Cardiothorac Surg . 2015;10(S1):A328.
doi:10.1186/1749-8090-10-s1-a328
37. Engoren M, Schwann TA, Habib RH. Elevated hemoglobin A1c is
associated with readmission but not complications. Asian
Cardiovasc Thorac Ann . 2014;22(7):800-806. doi:10.1177/0218492313515895
38. Aydınlı B, Demir A, Özmen H, Vezir Ö, Ünal U, Özdemir M. Can
pre-operative HbA1c values in coronary surgery be a predictor of
mortality? Turk Anesteziyoloji ve Reanimasyon Dern Derg .
2018;46(3):184-190. doi:10.5152/TJAR.2018.46667
39. Biskupski A, Waligórski S, Kowalik B, et al. Glycated hemoglobin
HbA1c - A new risk marker for the outcome of cardiac surgery?Kardiochirurgia i Torakochirurgia Pol . 2014;11(1):7-11.
doi:10.5114/kitp.2014.41922
40. B. F, J. B, J. H, et al. Elevated Hemoglobin A1c Is Associated With
Lower Socioeconomic Position and Increased Postoperative Infections and
Longer Hospital Stay After Cardiac Surgical Procedures. Ann Thorac
Surg . 2017;103(1):145-151. doi:10.1016/j.athoracsur.2016.05.092 LK -
http://WT3CF4ET2L.search.serialssolutions.com?sid=EMBASE&issn=15526259&id=doi:10.1016%2Fj.athoracsur.2016.05.092&atitle=Elevated+Hemoglobin+A1c+Is+Associated+With+Lower+Socioeconomic+Position+and+Increased+Postoperative+Infections+and+Longer+Hospital+Stay+After+Cardiac+Surgical%C2%A0Procedures&stitle=Ann.+Thorac.+Surg.&title=Annals+of+Thoracic+Surgery&volume=103&issue=1&spage=145&epage=151&aulast=Finger&aufirst=Brooke&auinit=B.&aufull=Finger+B.&coden=ATHSA&
41. Gatti G, Perrotti A, Reichart D, et al. Glycated hemoglobin and risk
of sternal wound infection after isolated coronary surgery. Circ
J . 2017;81(1):36-43. doi:10.1253/circj.CJ-16-0778
42. Göksedef D, Nail Ömeroğlu S, Şeyma E, Yalvaç D, Bitargil M, İpek G.Is Elevated HbA1c a Risk Factor for Infection after Coronary
Artery Bypass Grafting Surgery? Vol 18.; 2010.
43. Kinoshita T, Asai T, Suzuki T, Kambara A, Matsubayashi K.
Preoperative hemoglobin A1c predicts atrial fibrillation after off-pump
coronary bypass surgery. Eur J Cardio-thoracic Surg .
2012;41(1):102-107. doi:10.1016/j.ejcts.2011.04.011
44. Zheng J, Cheng J, Wang T, Zhang Q, Xiao X. Does HbA1c Level Have
Clinical Implications in Diabetic Patients Undergoing Coronary Artery
Bypass Grafting? A Systematic Review and Meta-Analysis. Int J
Endocrinol . 2017;2017:1537213. doi:10.1155/2017/1537213
45. Sato H, Carvalho G, Sato T, Lattermann R, Matsukawa T, Schricker T.
The association of preoperative glycemic control, intraoperative insulin
sensitivity, and outcomes after cardiac surgery. J Clin Endocrinol
Metab . 2010;95(9):4338-4344. doi:10.1210/jc.2010-0135
46. Knapik P, Cieśla D, Filipiak K, Knapik M, Zembala M. Prevalence and
clinical significance of elevated preoperative glycosylated hemoglobin
in diabetic patients scheduled for coronary artery surgery. Eur J
Cardio-Thoracic Surg . 2011;39(4):484-489.
doi:10.1016/j.ejcts.2010.07.037
47. Santos JM, Favaloro RR, Lowenstein D, Sanabria H, Raffaelli H,
Hershson A. Medium-term glycemic control in diabetics before coronary
bypass surgery. Medicina (B Aires) . 2015;75(5):277-281.
http://www.ncbi.nlm.nih.gov/pubmed/26502461. Accessed April 3, 2020.
48. Wang J, Luo X, Jin X, et al. Effects of Preoperative HbA1c Levels on
the Postoperative Outcomes of Coronary Artery Disease Surgical Treatment
in Patients with Diabetes Mellitus and Nondiabetic Patients: A
Systematic Review and Meta-Analysis. J Diabetes Res . 2020;2020.
doi:10.1155/2020/3547491
49. Gitt AK, Bramlage P, Binz C, Krekler M, Deeg E, Tschöpe D.
Prognostic implications of DPP-4 inhibitor vs. sulfonylurea use on top
of metformin in a real world setting - Results of the 1 year follow-up
of the prospective DiaRegis registry. Int J Clin Pract .
2013;67(10):1005-1014. doi:10.1111/ijcp.12179
50. Rathmann W, Kostev K, Gruenberger JB, Dworak M, Bader G, Giani G.
Treatment persistence, hypoglycaemia and clinical outcomes in type 2
diabetes patients with dipeptidyl peptidase-4 inhibitors and
sulphonylureas: A primary care database analysis. Diabetes, Obes
Metab . 2013;15(1):55-61. doi:10.1111/j.1463-1326.2012.01674.x
51. Najafi M, Goodarzynejad H. Determinants of length of stay in
surgical ward after coronary bypass surgery: glycosylated hemoglobin as
a predictor in all patients, diabetic or non-diabetic. J Tehran
Heart Cent . 2012;7(4):170-176.
http://www.ncbi.nlm.nih.gov/pubmed/23323078. Accessed April 3, 2020.
52. Medhi M, Marshall J, Burke HB, et al. HbA1c predicts length of stay
in patients admitted for coronary artery bypass surgery. Hear
Dis . 2001;3(2):77-79. doi:10.1097/00132580-200103000-00003
53. Almogati JG, Ahmed EO. Glycated hemoglobin as a predictor of the
length of hospital stay in patients following coronary bypass graft
surgery in the saudi population. Brazilian J Cardiovasc Surg .
2019;34(1):28-32. doi:10.21470/1678-9741-2018-0202
54. Arslan Ü, Memetoğlu ME, Kutlu R, et al. Cardiovascular surgery [
Preoperative Hba1c level in prediction of short-term morbidity and
mortality outcomes following coronary artery bypass grafting surgery.Russ Open Med J . 2015;4(2):204. doi:10.15275/rusomj.2015.0204
55. Finger B, Brase J, He J, Gibson WJ, Wirtz K, Flynn BC. Elevated
Hemoglobin A1c Is Associated With Lower Socioeconomic Position and
Increased Postoperative Infections and Longer Hospital Stay After
Cardiac Surgical Procedures. Ann Thorac Surg .
2017;103(1):145-151. doi:10.1016/j.athoracsur.2016.05.092
56. Prasad K. Does HbA1cc Play a Role in the Development of
Cardiovascular Diseases? Curr Pharm Des . 2018;24(24):2876-2882.
doi:10.2174/1381612824666180903121957
57. Romano E Silva AC, Dias GM, De Carvalho JJ, De Lorenzo A, Kasal DAB.
Research proposal: Inflammation and oxidative stress in coronary artery
bypass surgery graft: Comparison between diabetic and non-diabetic
patients. BMC Res Notes . 2018;11(1):635-635.
doi:10.1186/s13104-018-3743-5
58. Kosiborod M, Inzucchi SE, Krumholz HM, et al. Glucometrics in
patients hospitalized with acute myocardial infarction-defining the
optimal outcomes-based measure of risk. Circulation .
2008;117(8):1018-1027. doi:10.1161/CIRCULATIONAHA.107.740498
59. Stirban AO, Tschoepe D. Cardiovascular Complications in Diabetes
Targets and interventions. 2008. doi:10.2337/dc08-s257
60. Nwose EU, Richards RS, Bwititi PT. Cardiovascular risks in
prediabetes: Preliminary data on “vasculopathy triad.” N Am J
Med Sci . 2014;6(7):328. doi:10.4103/1947-2714.136913
61. Li YSJ, Haga JH, Chien S. Molecular basis of the effects of shear
stress on vascular endothelial cells. J Biomech .
2005;38(10):1949-1971. doi:10.1016/j.jbiomech.2004.09.030
62. Watala C, Witas H, Olszowska L, Piasecki W. The association between
erythrocyte internal viscosity, protein non-enzymatic glycosylation and
erythrocyte membrane dynamic properties in juvenile diabetes mellitus.Int J Exp Pathol . 1992;73(5):655-663.
http://www.ncbi.nlm.nih.gov/pubmed/1329916. Accessed April 3, 2020.
63. Kassaian SE, Goodarzynejad H, Boroumand MA, et al. Glycosylated
hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients
following coronary artery stenting. Cardiovasc Diabetol .
2012;11(1):82. doi:10.1186/1475-2840-11-82
64. Moura J, Madureira P, Leal EC, Fonseca AC, Carvalho E. Immune aging
in diabetes and its implications in wound healing. Clin Immunol .
2019;200:43-54. doi:10.1016/j.clim.2019.02.002
65. Bláha J, Mráz M, Kopecký P, et al. Perioperative tight glucose
control reduces postoperative adverse events in nondiabetic cardiac
surgery patients. J Clin Endocrinol Metab . 2015;100(8):3081-3089.
doi:10.1210/jc.2015-1959
66. A. F, P. C, D. S, et al. Prevalence and clinical outcome of
hyperglycemia in the perioperative period in noncardiac surgery.Diabetes Care . 2010;33(8):1783-1788. doi:10.2337/dc10-0304.
67. Kotagal M, Symons RG, Hirsch IB, et al. Perioperative hyperglycemia
and risk of adverse events among patients with and without diabetes.Ann Surg . 2015;261(1):97-103. doi:10.1097/SLA.0000000000000688
68. Jones CE, Graham LA, Morris MS, et al. Association between
preoperative hemoglobin A1c levels, postoperative hyperglycemia, and
readmissions following gastrointestinal surgery. JAMA Surg .
2017;152(11):1031-1038. doi:10.1001/jamasurg.2017.2350
69. Schmeltz LR, DeSantis AJ, Thiyagarajan V, et al. Reduction of
Surgical Mortality and Morbidity in Diabetic Patients Undergoing Cardiac
Surgery With a Combined. Diabetes Care . 2007;30(4):823-828.
doi:10.2337/dc06-2184.A.J.D.
70. Levy N, Dhatariya K. Pre-operative optimisation of the surgical
patient with diagnosed and undiagnosed diabetes: a practical review.Anaesthesia . 2019;74:58-66. doi:10.1111/anae.14510